HOT TOPICS IN HEART FAILURE

Sunday, March 9, 2025

3:15 PM – 4:35 PM ET

Moderator(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure information not submitted.
JoAnn Lindenfeld, MD

Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States

Disclosure information not submitted.
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure information not submitted.

Panel Discussant(s)

Parag Goyal, MD

Associate Professor of Medicine
NewYork-Presbyterian / Weill Cornell Medical Center, New York, United States

Disclosure information not submitted.
Scott M. Lilly, MD PhD

Professor
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States

Disclosure(s): Cardiac Dimensions: Consultant (Ongoing); DASI Simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing)
Donna Mancini, MD

Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure information not submitted.
MM

Martin Maron, MD

Director, HCM Center
Lahey Medical Center, Massachusetts, United States

Disclosure(s): Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)
John C. Messenger, MD

Professor of Medicine
University of Colorado School of Medicine
Aurora, Colorado, United States

Disclosure(s): Philips: Institutional grant support--University of Colorado SOM (Ongoing)
CR

Charles D. Resor, MD

Interventional Cardiologist
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Mark V. Sherrid, MD

Director, Hypertrophic Cardiomyopathy Program
New York University Health
New York City, New York, United States

Disclosure information not submitted.
Matthew Sherwood, MD, MHS

Director of Structural Heart Program
Inova Heart and Vascular Institute, Virginia, United States

Disclosure information not submitted.
Yan Topilsky, MD

Head of Non Invasive Cardiology
Tel-Aviv Sourasky Medical Center

Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)

Disclosure(s):

Scott M. Lilly, MD PhD: Cardiac Dimensions: Consultant (Ongoing); DASI Simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing)

Martin Maron, MD: Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)

John C. Messenger, MD: Philips: Institutional grant support--University of Colorado SOM (Ongoing)

Yan Topilsky, MD: Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)